Financial statements Bioestry

Balance sheet of Bioestry

Company age:
Age:
19 y. 10 m. 2 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of BIOESTRY

Year
2018
2019
2020
2021
2022
2023
Total assets 44 494 197,04 52 482 837,34 39 666 448,73 53 122 896,02 73 830 224,78 99 532 577,41
A. Fixed assets 12 595 353,55 12 383 312,50 12 048 957,83 12 578 201,87 12 182 515,74 11 791 363,28
B. Current assets 31 898 843,49 40 099 524,84 27 617 490,90 40 544 694,15 61 647 709,04 87 741 214,13
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 44 494 197,04 52 482 837,34 39 666 448,73 53 122 896,02 73 830 224,78 99 532 577,41
A. Equity 15 971 443,23 16 434 524,23 17 501 263,41 19 225 185,43 20 643 810,89 21 745 171,12
B. Liabilities and provisions for liabilities 28 522 753,81 36 048 313,11 22 165 185,32 33 897 710,59 53 186 413,89 77 787 406,29
I. Long-term liabilities 6 655 414,39 4 505 888,54 4 357 290,52 2 016 956,46 953 664,64 624 382,32
II. Short-term liabilities 20 219 021,53 29 724 802,49 15 492 734,16 31 873 264,03 52 230 422,72 77 162 805,65
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.